Moreover, the fact that B16 cells are PD-L1 positive and that CD3+ T cells were also positive for PD-1, means that one should consider continued vaccinations post-tumour implantation, as well as consider the inclusion of anti-PD-1 antibody therapy. Here, PDCD1 is linked to neoplasm.